A brand built to carry a heritage further
SLA Health is an independent global nutrition and wellness brand built on four decades of folate research. The brand is designed to grow from maternal nutrition into healthy aging and everyday family nutrition, without changing its name or its story. Pregnancy is where the heritage is deepest; it is not the boundary of the brand.
The reason for going global is straightforward. The folate science behind this brand was built through international research partnerships, and it is useful well beyond pregnancy, and well beyond one market. Families elsewhere ask the same questions about nutrition at different stages of life — and there was no vehicle to answer them in a global voice.
SLA Health is that vehicle. It is not a new science project, and it is not a localised copy of an existing label. It is the same research heritage, carried forward with an international identity.
40 Years of Folate Science
* Doses reference published evidence and a supplementary reference dose; follow the label or your clinician's advice.
* English wording follows the certificate on file; to be confirmed before publication.
Forty years, ten marks
- A global vision for better health
SLA Health carries this heritage into maternal, family and healthy aging nutrition worldwide.
- A scientific beginning
Neural tube defect rates reported at an international perinatal meeting point to folate as a modifiable factor.
- Research collaboration with the US CDC
A research relationship with the US Centers for Disease Control and Prevention is formalised.
- An international research programme
A multi-country programme on the prevention of neural tube defects is launched.
- A public health recommendation
- The US Public Health Service recommends
- 4 mg folic acid daily for women planning a pregnancy.
- Evidence at scale
A 13-year programme covering 250,000 women of childbearing age, with more than US$20 million invested.
- Publication in The Lancet
- Results establish
- 4 mg as the reference dose and are published in The Lancet.
- A global reference dose
- The findings enter the international clinical literature, and
- 4 mg becomes the dose cited by WHO.
- International advocacy
A WHO-supported international congress puts birth-defect and disability prevention on the global agenda.
- Recognition of the heritage
- Market-position certification for the
- 4 mg folate standard.*